Copyright
©The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. May 28, 2018; 24(20): 2163-2172
Published online May 28, 2018. doi: 10.3748/wjg.v24.i20.2163
Published online May 28, 2018. doi: 10.3748/wjg.v24.i20.2163
Characteristics and predictors of gastric cancer after Helicobacter pylori eradication
Satoki Shichijo, Department of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka 541-8567, Japan
Yoshihiro Hirata, Division of Advanced Genome Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan
Author contributions: Shichijo S drafted the article; and Hirata Y critically revised and approved the final article.
Supported by (partly) JSPS KAKENHI, No. 17K09346 and No. 16K09279.
Conflict-of-interest statement: The authors declare that no competing interests exist.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Yoshihiro Hirata, MD, PhD, Associate Professor, Division of Advanced Genome Medicine, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan. yohirata@ims.u-tokyo.ac.jp
Telephone: +81-3-64092335 Fax: +81-3-64092336
Received: March 27, 2018
Peer-review started: March 28, 2018
First decision: April 19, 2018
Revised: May 4, 2018
Accepted: May 18, 2018
Article in press: May 18, 2018
Published online: May 28, 2018
Processing time: 62 Days and 9.4 Hours
Peer-review started: March 28, 2018
First decision: April 19, 2018
Revised: May 4, 2018
Accepted: May 18, 2018
Article in press: May 18, 2018
Published online: May 28, 2018
Processing time: 62 Days and 9.4 Hours
Core Tip
Core tip: Gastric cancer develops even after successful Helicobacter pylori (H. pylori) eradication therapy. With the prevalence of eradication therapy, occurrence rates of gastric cancer detected after eradication are increasing and this is becoming an important clinical issue. We review the characteristics and predictors of primary gastric cancer after H. pylori eradication, and discuss the risk stratification of gastric cancer after eradication.